Watson-Marlow Fluid Technology Solutions focuses on BioClamp's sustainability benefits and new WMArchitect Interchangeable Parts service at INTERPHEX Tokyo 2025

TOKYO, July 9, 2025 /PRNewswire/ -- Visitors to the Watson-Marlow Fluid Technology Solutions booth W15-2 at INTERPHEX Tokyo 2025 (July 9-11 at Tokyo Big Sight, Japan) can learn more about the new WMArchitect Interchangeable Parts service as well as how recently advanced manufacturing of BioClamp is bringing sustainability benefits to users.

The single-use sanitary BioClamp^®, from BioPure, has been re-engineered in both its design and manufacturing process. Visitors to booth 15-2 can discover how BioClamp is manufactured to be 13% lighter than the previous model, with a 26% reduction in carbon dioxide emissions across the full lifecycle of the product.

BioClamp is one of multiple innovative solutions WMFTS offers for pharmaceutical and biotechnology companies, including expert services, peristaltic pumps, tubing, assemblies, and valves.  Competitive bulk order prices are available due to the highly efficient manufacturing methods of BioClamp, which securely attaches sanitary fittings and is ideal for single-use critical fluid transfer lines.

Following the release of WMArchitectâ„¢ single-use solutions last year, the Interchangeable Parts service allows users to reduce single-use component supply limitations by incorporating pre-qualified, alternative components into their single-use assemblies. 

The versatile service eliminates the disruption of reduced stock and potential for production shutdown, as well as avoiding the need to evaluate substitute parts quickly in time-sensitive incidents. This service meets industry best practices and has been developed according to industry working group consensus on interchangeability of components.

According to Market Data Forecast, the Asia Pacific biopharmaceuticals market was valued at $44.3 billion in 2023 and is expected to be worth $78.69 billion by 2029 with a CAGR of 10.05 per cent from 2024 to 2029.

Jacky Chan, WMFTS APAC Division Director, said: "Asia is poised to become a manufacturing powerhouse for biopharmaceutical with the macro trends of the rise of decentralised clinical trials (DCTs), personalised medicine, cell and gene therapy (CGT), the expansion of mRNA technologies, and focus on biosimilars. Watson-Marlow Fluid Technology Solutions is here to support the growth of pharma manufacturing by providing an end-to-end biopharmaceutical fluid management solution from a single supplier including the newly launched Interchangeable Parts service. This improvement in supply agility avoids regulatory compliance interruptions when component availability is disrupted. Meanwhile BioClamp is re-engineered to support our customers' sustainability journey in reducing carbon footprint." 

Akira Uozumi, Regional General Manager of Northeast Asia Region, said: "Our peristaltic pumps and compatible fluid path solutions are renowned in the pharmaceutical and biotechnology sectors. Visitors to our booth at INTERPHEX Tokyo will be able to discover more about our solutions for upstream, downstream and final fill/finish applications. For example, BioPure delivers high-purity fluid transfer components designed to maintain sterility and integrity in biopharmaceutical manufacturing meanwhile Flexicon offers scalable, aseptic filling solutions that maintain sterility and accuracy, ideal for sensitive drug production."

The team who are present at the booth are Hironobu Kirii, Sales leader; Steven Lin, Sales Engineer; Suzuki Sales Leader, and Faith Tang, Head of APAC Marketing. Faith Tang is holding a media briefing to the Japanese media at the booth on July 9 afternoon to explain BioClamp and new WMArchitect Interchangeable Parts service to the market.

Visit WMFTS at stand W15-2 at INTERPHEX Tokyo to learn more about its innovative fluid management solutions for life sciences applications. Any further enquiries please contact WMFTS Japan team at info.jp@wmfts.com and +81 3 5918 8101, +81-3-3967-8161.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Watson-Marlow Fluid Technology Solutions focuses on BioClamp's sustainability benefits and new WMArchitect Interchangeable Parts service at INTERPHEX Tokyo 2025

GUANGZHOU, China, Jan. 11, 2026 /PRNewswire/ -- Recently, GAC's independently developed Quark E-Drive power domain control system has achieved the world's first dual certification for deeply integrated ASIL D functional safety and information security, accredited by DAkkS, Germany's national accreditation body. The certification was evaluated and issued by SGS-CSTC Standards Technical Services Co., Ltd. (SGS), a globally recognized certification authority.

ISO 26262 is the internationally recognized core standard for automotive functional safety. Within this framework, ASIL D represents the highest automotive safety integrity level, requiring near-zero tolerance for safety-critical failures. Achieving an ASIL D certification accredited by DAkkS signifies that the certified product meets the highest globally accepted standards for automotive safety.

The certified Quark E-Drive power domain control system has been in production use since February 2025, and is now deployed across multiple models under GAC's brands - HYPTEC and AION. As the industry's first electric drive power domain system based on deep integration using a single main control chip, the solution significantly reduces chip count, minimizes risks associated with chip-level failures, and boosts motor controller efficiency to as high as 99.9%. The certification confirms that GAC has completed the system's full product development lifecycle in strict compliance with ISO 26262:2018 functional safety and ISO/SAE 21434:2021 information security standards.

Throughout the project, GAC Technology Research Center worked closely with SGS experts, strengthening safety design across all development phases while ensuring engineering feasibility and an optimal user experience.

Zhao Hui, Vice President of SGS China, commented: "The successful certification highlights GAC's strong team and robust development systems. We are pleased to support the safety of the Quark E-Drive and look forward to closer collaboration."

This milestone represents a major breakthrough for GAC in e-drive safety and sets a new global benchmark for the intelligent electric vehicle industry.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

GAC's Quark Electric Drive Achieves the World's First DAkkS ASIL D Functional Safety and Information Security Dual Certification